Asia Pacific Oligonucleotide Synthesis Market worth $4.88 billion by 2030
The report "Asia Pacific Oligonucleotide Synthesis Market by Product {Drugs [ASO, siRNA], Synthesized Oligos [Product (Primers, Probes), Type (Custom, Predesigned)], Reagents, Equipment}, Application (Therapeutic, Research, Diagnostics) - Forecast to 2030", is projected to reach USD 4.88 billion by 2030, from USD 2.08 billion in 2025, with a CAGR of 18.5%.
Browse 300 market data Tables and 35 Figures spread through 250 Pages and in-depth TOC on "Asia Pacific Oligonucleotide Synthesis Market by Product {Drugs [ASO, siRNA], Synthesized Oligos [Product (Primers, Probes), Type (Custom, Predesigned)], Reagents, Equipment}, Application (Therapeutic, Research, Diagnostics) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asia-pacific-oligonucleotide-synthesis-market-67932775.html
Several factors are fueling the growth of the Asia Pacific oligonucleotide synthesis market. A key driver is the region’s expanding number of pharma and biotech companies advancing ASO, siRNA, and gene editing programs. As more of these pipelines transition from early research to clinical development, demand is increasing for GMP-grade, high-purity oligos. This sustains higher spending on core synthesis chemistries, purification, and advanced analytical testing.
Based on product, oligonucleotide-based drugs accounted for the largest market share in 2024.
The Asia Pacific oligonucleotide synthesis market is segmented by product into oligonucleotide-based drugs, synthesized oligonucleotides, reagents & consumables, and equipment. In 2024, the oligonucleotide-based drugs segment held the largest share of revenue, mainly due to the rising use of such drugs for targeted treatment of chronic and genetic diseases.
Based on application, therapeutic applications dominated the Asia Pacific oligonucleotide synthesis market in 2024.
The Asia Pacific oligonucleotide synthesis market is segmented by application into therapeutic applications, research applications, and diagnostic applications. In 2024, the therapeutic applications segment dominated the market mainly due to the high revenue from oligonucleotide drugs. As regulatory approvals increase, this segment is expected to keep holding a significant market share.
China is expected to lead the growth of the Asia Pacific oligonucleotide synthesis market between 2025 and 2030.
The Asia Pacific market comprises China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China is projected to record the highest growth rate. The country has a large and expanding base of biotech and biopharma companies, primarily those developing RNA medicines (SIRNA/ASO) and gene editing programs. Consequently, there is an increasing demand for GMP-grade therapeutic oligos at the preclinical, clinical, and early commercial stages.
Key companies active in the Asia Pacific oligonucleotide synthesis market include Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Biogen (US), Alnylam Pharmaceuticals, Inc. (US), Agilent Technologies, Inc. (US), Astellas Pharma Inc. (Japan), and Nippon Shinyaku, Co. Ltd. (Japan).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Asia Pacific Oligonucleotide Synthesis Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
